SPP1 and COVID-19: Hayek and colleagues demonstrated that elevated circulating levels of OPN in 341 patients treated for COVID-19 in four tertiary care centers in four Western countries directly reflect disease severity and represent an independent risk factor for a more severe clinical course [47].